Newsroom

Industry News

24 Feb

OncoSec to Host KOL Event Focused on New ASCO-SITC Melanoma Data and Clinical Strategy on Tuesday, February 28 in New York City

SAN DIEGO, Feb. 24, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec”) (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will host a Key Opinion Leader event to highlight new clinical data that will be featured as an oral and poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the...

Read more

24 Feb

Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR

TORONTO, Feb. 24, 2017 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I)  (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs announced that the Company today received final approval from the U.S. Food...

Read more

23 Feb

OncoSec Announces Positive Phase II Data Demonstrating Company’s ImmunoPulse® IL-12 in Combination with Pembrolizumab Increased Response Rates in Anti-PD-1 Non-Responder Melanoma Patients

SAN DIEGO, Feb. 23, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec”) (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today reported new positive clinical data from a Phase II Investigator Sponsored Trial assessing the combination of OncoSec’s investigational intratumoral therapy, ImmunoPulse® IL-12, and the approved anti-PD- 1 therapy (pembrolizumab), in...

Read more

22 Feb

NABUFIT Debuts Sir Mo Farah Videos for its Physical Fitness App

NEW YORK, Feb. 22, 2017 (GLOBE NEWSWIRE) — NABUFIT Global Inc. (OTCQB:NBFT), developer of a ground breaking new training portal that enhances individual workouts by providing expert advice from professional trainers, health experts and international sports stars, today announced the debut of its workout routines and videos of the Double Olympic...

Read more

22 Feb

NuGene International Appoints S. David Ollie As Vice President, Sales

IRVINE, CA–(Marketwired – Feb 22, 2017) – NuGene International, Inc. (“NuGene”) ( OTCQB : NUGN ), a developer, manufacturer, and marketer of advanced skin and hair care lines utilizing human adipose derived stem cell conditioned media, today announced that it has appointed S. David Ollie as Vice President, Sales....

Read more

21 Feb

Actinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and Commercial Strategy

NEW YORK, Feb. 21, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc.  (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Steven Price has been appointed to the newly created position of Vice President, Clinical and Commercial...

Read more

21 Feb

Celsion Corp. Cancer Medications Insider Buying and Analysis

NEW YORK, NY / ACCESSWIRE / February 21, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is covering Celsion Corp. (CLSN) today, in light of recent insider buying. In the recent past, Celsion reported several Insider...

Read more

21 Feb

Youngevity Debuts Online Lifestyle Destination At youngevitybeta.com

SAN DIEGO, CA–(Marketwired – Feb 21, 2017) – Youngevity International, Inc. ( OTCQX : YGYI ), the only omni-direct lifestyle company, today announced the beta launch of its anticipated revolutionary and all-inclusive new online destination — temporarily housed at www.youngevitybeta.com. When the site is formally launched as expected at the...

Read more

Page 1 of 21612345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address